Use of naltrexone/bupropion in adults with class III obesity: a case series of two patients

J, Thesapiriya and M, Aimi Fadilah and Ew, Nur Aini and A, Mohd Hazriq and B, Nur Haziqah and MS, Fatimah Zaherah and AG, Rohana (2026) Use of naltrexone/bupropion in adults with class III obesity: a case series of two patients. Journal of Clinical and Health Sciences (JCHS), 11 (SUPP2). pp. 45-46. ISSN 0127-984X

Official URL: https:// jchs-medicine.uitm.edu.my

Abstract

Obesity is a chronic, multifactorial disease. Lifestyle modification remains the cornerstone of obesity management, but pharmacological therapy is often required to achieve clinically meaningful weight loss. Naltrexone/bupropion is an approved anti-obesity medication that acts centrally to reduce appetite and food cravings. This case series described weight loss outcomes in two patients treated with Naltrexone/bupropion in combination with lifestyle interventions.

Item Details

Item Type:	Article
Creators:	Creators Email / ID Num. J, Thesapiriya thesa.piriya@gmail.com M, Aimi Fadilah UNSPECIFIED Ew, Nur Aini UNSPECIFIED A, Mohd Hazriq UNSPECIFIED B, Nur Haziqah UNSPECIFIED MS, Fatimah Zaherah UNSPECIFIED AG, Rohana UNSPECIFIED
Subjects:	R Medicine > RC Internal Medicine > Neurotoxicology R Medicine > RC Internal Medicine > Specialties of internal medicine > Metabolic diseases
Divisions:	Universiti Teknologi MARA, Selangor > Sungai Buloh Campus > Faculty of Medicine
Journal or Publication Title:	Journal of Clinical and Health Sciences (JCHS)
ISSN:	0127-984X
Event Title:	2nd National Obesity Scientific Conference
Event Dates:	11-12 April 2026
Volume:	11
Number:	SUPP2
Page Range:	pp. 45-46
Keywords:	Naltrexone/bupropion, Class III obesity, Severe obesity, Anti-obesity agents, Pharmacotherapy, Weight management, Case series
Date:	September 2026
URI:	https://ir.uitm.edu.my/id/eprint/147676

: Edit Item

Downloads & Files

Text
147676.pdf

Download (227kB)

Indexing & Metrics